COVID-19

The COVA study (NCT04472728) was a double-blind, placebo-controlled phase 2 to 3 study that investigated BIO101 for the prevention of respiratory deterioration in hospitalized COVID-19. touchRESPIRATORY were delighted to speak with Dr. Girish B. Nair (Beaumont Health, Royal Oak, MI, USA) around the mechanism of action of BIO101, the design, inclusion criteria and findings from […]

Longitudinal studies into the long-term impact of COVID-19 are currently at the forefront of research, touchRESPIRATORY interviewed editorial board member Prof. Margaret Pisani (Yale School of Medicine. New Haven, CT, USA) about what to look out for in 2023 in this area. Disclosures: Margaret Pisani has nothing to disclose in relation to this video interview. Support: Interview and filming […]

The IPCRG COVID-19 and Respiratory Q&A is providing evidence based COVID and respiratory advice to practising primary care clinicians. Prof. Alan Kaplan (University of Toronto, Toronto, ON, Canada) answers questions from the Q&A on managing COVID-19, how to address the controversies surrounding the COVID-19 vaccines, and the immunity provided from COVID-19 vaccination and booster doses. […]

touchRESPIRATORY caught up with Dr Fiona Mosgrove (University of Aberdeen Medical School, Aberdeen, Scotland) to discuss the COVID-19 and respiratory Q&A created by IPCRG and to answer some of the key questions around the variants of SARS-CoV-2, treatments for COVID-19 and what will happen as we move out of the pandemic. Questions Could you give […]

The COVID-19 pandemic remains an international public health emergency, and the emergence of new SARS-CoV-2 variants highlights concerns regarding COVID-19 breakthrough infections. Understanding emerging SARS-CoV-2 variants is especially important as the medical and public health community seeks to contain COVID-19. In this interview, Dr Hiam Chemaitelly (Weill Cornell Medicine-Qatar, Ar-Rayyan, Qatar) talked to us about […]

INVENT COVID was a phase II study, which investigated the efficacy and safety of intravenous imatinib in acute respiratory distress syndrome induced by COVID-19 (Clinical Trials Identifier: NCT04794088). touchRESPIRATORY were delighted to speak with Dr. Leila Atmowihardjo (Amsterdam Medical Centers: Academic Medical Center, Amsterdam, The Netherlands) to discuss the aims, design, eligibility criteria and findings […]

This analysis of COVIDENCE UK investigated potential sociodemographic, behavioural, clinical, pharmacological and nutritional determinants of antibody responses to administration of SARS-CoV-2 vaccination and booster doses. It was a pleasure to talk with Professor Adrian Martineau (Queen Mary University of London, London, UK) around the aims, methodology and patient population of the COVIDENCE UK study and […]

CORONAVIT was a phase 3 randomized controlled trial, investigating the potential of vitamin D to reduce incidence and severity of acute respiratory infections (ARI) and COVID-19. touchRESPIRATORY were delighted to speak with Professor Adrian Martineau (Queen Mary University of London, London, UK) to learn more around the aims, design and outcome measures of the phase […]